EXECUTIVE ENGAGEMENTS
POOL
1514
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
279
Interactions with Platform & by Email
PARTICIPANTS
93
Unique # Participated
VALIDATIONS
54
Responses Validated*
COMPANIES
137
Responses Validated*
* Login for a full stack data experience
DATE
OCT 2022
TABLES
312
PAGES
693
EDITION
19
PRICE
USD 5450
CODE
MCP-1889
*Engagement stats are ongoing and dynamic
RESEARCH MODULES
EXECUTIVES
HIGHLIGHTS & REPORT INDEX
What`s New for 2022?
» Global competitiveness and key competitor percentage market shares
» Market presence across multiple geographies - Strong/Active/Niche/Trivial
» Online interactive peer-to-peer collaborative bespoke updates
» Access to our digital archives and MarketGlass Research Platform
» Complimentary updates for one year
Global Radiopharmaceuticals Market to Reach $9.5 Billion by 2027
In the changed post COVID-19 business landscape, the global market for Radiopharmaceuticals estimated at US$5.3 Billion in the year 2020, is projected to reach a revised size of US$9.5 Billion by 2027, growing at a CAGR of 8.7% over the analysis period 2020-2027. SPECT Radioisotopes, one of the segments analyzed in the report, is projected to record a 8.1% CAGR and reach US$4.1 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Pet Radioisotopes segment is readjusted to a revised 9.5% CAGR for the next 7-year period.
The U.S. Market is Estimated at $2.5 Billion, While China is Forecast to Grow at 11.3% CAGR
The Radiopharmaceuticals market in the U.S. is estimated at US$2.5 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$591.5 Million by the year 2027 trailing a CAGR of 11.3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.7% and 6.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7.6% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$513.6 Million by the year 2027.
Beta Emitters Segment to Record 10.8% CAGR
In the global Beta Emitters segment, USA, Canada, Japan, China and Europe will drive the 10.8% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$744.7 Million in the year 2020 will reach a projected size of US$1.5 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Latin America will expand at a 10.5% CAGR through the analysis period.
SELECT PLAYERS
Actinium Pharmaceuticals, Inc.; Alliance Medical; Avid Bioservices Inc; Bayer HealthCare Pharmaceuticals; Bracco Diagnostics, Inc.; Cardinal Health, Inc.; GE Healthcare; Ion Beam Applications S.A; Jubilant Pharma; Lantheus Medical Imaging Inc.; Medi-Radiopharma Ltd; Nordion, Inc.; Novartis/Advanced Accelerator Applications; Positron Corporation; Radiopharm Theranostics Ltd.
SEGMENTS
» Product Type (SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters, Other Product Types) » Application (Oncology, Cardiology, Neurology, Other Applications) » End-Use (Hospitals & Diagnostic Centers, Ambulatory Surgical Centers, Other End-Uses)
GEOGRAPHIES
» World » USA » Canada » Japan » China » Europe » France » Germany » Italy » UK » Spain » Russia » Rest of Europe » Asia-Pacific » Australia » India » South Korea » Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » UAE » Rest of Middle East » Africa
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Impact of COVID-19 and a Looming Global Recession |
| 2020: A Year of Disruption & Transformation |
| As the Race between the Virus & Vaccines Intensifies, Where is the World Economy Headed in 2021? |
| Pandemic-Led Disruptions Affect Radiopharmaceuticals Supply, Hindering Nuclear Medicine Procedures in Several Countries |
| EXHIBIT: Imaging Screening Volume % Change 1H 2019 Vs 1H 2020 in US Hospitals |
| Distribution Bottlenecks amid COVID-19 Crisis Leave Hospitals Struggling with Supply of Medical Radioisotopes |
| Nuclear Medicine Services Limp Back to Normalcy after Easing of COVID-19 Restrictions |
| COVID-19 Presents Generational Opportunity |
| Radiopharmaceuticals – Global Key Competitors Percentage Market Share in 2022 (E) |
| Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E) |
| An Introduction to Radiopharmaceuticals |
| Mechanism of Action |
| Global Market Prospects & Outlook |
| Key Market Drivers |
| Market Restraints |
| Recognition of Intrinsic Cost Benefits: Critical to Market Acceptance |
| Classification of Radiopharmaceuticals |
| Diagnostic Radiopharmaceuticals: The Dominant Segment |
| Key Drivers |
| Positron Emission Tomography (PET) |
| Single Photon Emission Computed Tomography (SPECT) |
| Therapeutic Radiopharmaceuticals |
| Global Supply Shortages Continue to Challenge Market Growth |
| EXHIBIT: A Glimpse at Mo-99 Processors Worldwide |
| EXHIBIT: Nuclear Research Reactor Irradiators Worldwide: A Snapshot |
| Competitive Landscape |
| EXHIBIT: Radiopharmaceuticals Competitor Market Share Scenario Worldwide (in %): 2020 |
| World Brands |
| Recent Industry Activity |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| Emergence of Radiotheranostics: Dual-Functioning Radiopharmaceuticals |
| EXHIBIT: Common Radionuclides Used in Theranostic Applications |
| Radiopharmaceuticals Become Promising for Cancer Theranostics |
| Changing Role of Radiopharmaceuticals in Diagnostic and Therapeutic Applications |
| Advent of New Radiopharmaceuticals Widen Scope |
| Select New Products |
| Startups Develop Unique Radiopharmaceutical Solutions |
| Potential Role of Carbon Dots in Imaging and Theranostics |
| Nano Radiopharmaceuticals: Promising Role in Therapeutic and Imaging Applications |
| Researchers Develop New Nanoparticles to Improve Radiopharmaceutical Efficiency |
| Oncoinvent and NPL Develops Unique Method to Measure & Deliver Dosages in Radiotherapy |
| Industry Focus Gears up for Innovative Radiopharmaceuticals with Therapeutic Benefits |
| Select Commercially Available Therapeutic Radiopharmaceuticals |
| Role of Radiopharmaceuticals as Diagnostic Technology |
| PET Eclipses SPECT in Cardiovascular Imaging |
| EXHIBIT: Worldwide Installed Base of Nuclear Imaging Equipment by Modality, PET Vs SPECT: 2020 |
| Cardiac Amyloidosis Visualization: A Potential Application for PET |
| Innovative Radiopharmaceuticals to Boost Cardiac Applications |
| EXHIBIT: Fatalities by Heart Conditions - Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others |
| Radiopharmaceuticals: Direct and Targeted Approach for Cancer Treatment |
| Rising Cancer Incidence Worldwide Spurs Demand |
| EXHIBIT: Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040 |
| EXHIBIT: Global Number of New Cancer Cases and Cancer-related Deaths by Cancer Site for 2020 |
| EXHIBIT: Number of New Cancer Cases and Deaths (in Million) by Region for 2020 |
| Intra-operative Lymphatic Mapping (ILM): Creates New Opportunities for Radiopharmaceuticals in Cancer Detection |
| Growing Prominence of Therapeutic Radiopharmaceuticals for Cancer Care |
| Rise in Incidence of Neurological Disorders to Drive Growth |
| Application of PET in Drug Development to Expand Opportunities |
| Personalized Medicine Drives Nuclear Medicine |
| EXHIBIT: Drug Ineffectiveness for Select Therapeutic Categories as a Percentage of Patient Population |
| EXHIBIT: Global Personalized Medicine Market: Revenues in US$ Million for the Years 2019 and 2024 |
| Gallium-68-labeled Radiopharmaceuticals: Production & Administering Challenges |
| Radiopharmaceuticals for COVID-19: Role in Diagnosis, Prognosis, and Therapeutic Uses |
| Artificial Intelligence: A Promising Tool in Radiotherapy and Radiopharmaceuticals |
| Aging Global Population: A Vital Demography |
| EXHIBIT: Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050 |
| EXHIBIT: Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030 |
| EXHIBIT: Global Cancer Deaths by Age Group (in %) for 2019 |
| Rise in Healthcare Expenditure to Drive Growth |
| EXHIBIT: World Healthcare Expenditure (In US$ Trillion) for the Years for 2017, 2019, 2021 & 2023 |
| EXHIBIT: Elderly Healthcare Expenditure as a % of GDP in the US, Europe and Japan for 1970, 2010 and 2050 |
| Relevant Aspects of Radiopharmaceutical Production |
| Regulatory Regime Governing Production and Use of Radiopharmaceuticals |
| The Facilitating Innovative Nuclear Diagnostics (FIND) Act, 2021 |
| Challenges Facing Nuclear Medicine Industry |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Recent Past, Current & Future Analysis for Radiopharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Radiopharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| World 11-Year Perspective for Radiopharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2016, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for SPECT Radioisotopes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for SPECT Radioisotopes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| World 11-Year Perspective for SPECT Radioisotopes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for PET Radioisotopes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for PET Radioisotopes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| World 11-Year Perspective for PET Radioisotopes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Beta Emitters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Beta Emitters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| World 11-Year Perspective for Beta Emitters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Alpha Emitters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Alpha Emitters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| World 11-Year Perspective for Alpha Emitters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| World 11-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| World 11-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| World 11-Year Perspective for Cardiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| World 11-Year Perspective for Neurology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| World 11-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Hospitals & Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Hospitals & Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| World 11-Year Perspective for Hospitals & Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Ambulatory Surgical Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Ambulatory Surgical Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| World 11-Year Perspective for Ambulatory Surgical Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| World 11-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2021 & 2027 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| Radiopharmaceuticals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E) |
| Market Overview |
| Diagnostic Applications Stimulate Future Growth |
| Demographic Changes Offer Growth Opportunities |
| EXHIBIT: US Elderly Population: Expected Growth Rates (%) Over the Years 2005-2025 |
| Rising Incidence of Cancer: A Major Growth Driver |
| EXHIBIT: Estimated Number of New Cancer Cases in the US by Gender and Affected Site for 2021 |
| EXHIBIT: Estimated Number of Cancer-Related Deaths in the US by Gender and Body Site for 2021 |
| EXHIBIT: Estimated Number of New Cancer Cases in the US by State for 2021 |
| EXHIBIT: Estimated Number of Cancer-Related Deaths in the US by State for 2021 |
| Cardiovascular Imaging to Lead Volume Growth |
| Radiopharmaceuticals Usage Grows in PET Imaging |
| Radioisotope/Radiopharmaceuticals Supply Scenario |
| Passing of Medicare Diagnostic Radiopharmaceutical Payment Equity Act |
| USA Recent Past, Current & Future Analysis for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| USA 11-Year Perspective for Radiopharmaceuticals by Product Type - Percentage Breakdown of Value Sales for SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types for the Years 2016, 2021 & 2027 |
| USA Recent Past, Current & Future Analysis for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| USA 11-Year Perspective for Radiopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2016, 2021 & 2027 |
| USA Recent Past, Current & Future Analysis for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| USA 11-Year Perspective for Radiopharmaceuticals by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2021 & 2027 |
| CANADA |
| Market Overview |
| Efforts on to Address Mo-99 Supply Shortage |
| Canada Recent Past, Current & Future Analysis for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| Canada 11-Year Perspective for Radiopharmaceuticals by Product Type - Percentage Breakdown of Value Sales for SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types for the Years 2016, 2021 & 2027 |
| Canada Recent Past, Current & Future Analysis for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| Canada 11-Year Perspective for Radiopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2016, 2021 & 2027 |
| Canada Recent Past, Current & Future Analysis for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| Canada 11-Year Perspective for Radiopharmaceuticals by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2021 & 2027 |
| JAPAN |
| Radiopharmaceuticals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E) |
| Market Overview |
| Japan Recent Past, Current & Future Analysis for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| Japan 11-Year Perspective for Radiopharmaceuticals by Product Type - Percentage Breakdown of Value Sales for SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types for the Years 2016, 2021 & 2027 |
| Japan Recent Past, Current & Future Analysis for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| Japan 11-Year Perspective for Radiopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2016, 2021 & 2027 |
| Japan Recent Past, Current & Future Analysis for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| Japan 11-Year Perspective for Radiopharmaceuticals by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2021 & 2027 |
| CHINA |
| Radiopharmaceuticals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E) |
| Market Overview |
| China Recent Past, Current & Future Analysis for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| China 11-Year Perspective for Radiopharmaceuticals by Product Type - Percentage Breakdown of Value Sales for SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types for the Years 2016, 2021 & 2027 |
| China Recent Past, Current & Future Analysis for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| China 11-Year Perspective for Radiopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2016, 2021 & 2027 |
| China Recent Past, Current & Future Analysis for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| China 11-Year Perspective for Radiopharmaceuticals by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2021 & 2027 |
| EUROPE |
| Radiopharmaceuticals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E) |
| Market Overview |
| Europe Recent Past, Current & Future Analysis for Radiopharmaceuticals by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Radiopharmaceuticals by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| Europe 11-Year Perspective for Radiopharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2016, 2021 & 2027 |
| Europe Recent Past, Current & Future Analysis for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| Europe 11-Year Perspective for Radiopharmaceuticals by Product Type - Percentage Breakdown of Value Sales for SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types for the Years 2016, 2021 & 2027 |
| Europe Recent Past, Current & Future Analysis for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| Europe 11-Year Perspective for Radiopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2016, 2021 & 2027 |
| Europe Recent Past, Current & Future Analysis for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| Europe 11-Year Perspective for Radiopharmaceuticals by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2021 & 2027 |
| FRANCE |
| Radiopharmaceuticals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E) |
| France Recent Past, Current & Future Analysis for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| France 11-Year Perspective for Radiopharmaceuticals by Product Type - Percentage Breakdown of Value Sales for SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types for the Years 2016, 2021 & 2027 |
| France Recent Past, Current & Future Analysis for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| France 11-Year Perspective for Radiopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2016, 2021 & 2027 |
| France Recent Past, Current & Future Analysis for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| France 11-Year Perspective for Radiopharmaceuticals by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2021 & 2027 |
| GERMANY |
| Radiopharmaceuticals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E) |
| Germany Recent Past, Current & Future Analysis for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| Germany 11-Year Perspective for Radiopharmaceuticals by Product Type - Percentage Breakdown of Value Sales for SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types for the Years 2016, 2021 & 2027 |
| Germany Recent Past, Current & Future Analysis for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| Germany 11-Year Perspective for Radiopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2016, 2021 & 2027 |
| Germany Recent Past, Current & Future Analysis for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| Germany 11-Year Perspective for Radiopharmaceuticals by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2021 & 2027 |
| ITALY |
| Italy Recent Past, Current & Future Analysis for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| Italy 11-Year Perspective for Radiopharmaceuticals by Product Type - Percentage Breakdown of Value Sales for SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types for the Years 2016, 2021 & 2027 |
| Italy Recent Past, Current & Future Analysis for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| Italy 11-Year Perspective for Radiopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2016, 2021 & 2027 |
| Italy Recent Past, Current & Future Analysis for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| Italy 11-Year Perspective for Radiopharmaceuticals by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2021 & 2027 |
| UNITED KINGDOM |
| Radiopharmaceuticals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E) |
| UK Recent Past, Current & Future Analysis for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| UK 11-Year Perspective for Radiopharmaceuticals by Product Type - Percentage Breakdown of Value Sales for SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types for the Years 2016, 2021 & 2027 |
| UK Recent Past, Current & Future Analysis for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| UK 11-Year Perspective for Radiopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2016, 2021 & 2027 |
| UK Recent Past, Current & Future Analysis for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| UK 11-Year Perspective for Radiopharmaceuticals by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2021 & 2027 |
| SPAIN |
| Spain Recent Past, Current & Future Analysis for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Spain Historic Review for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| Spain 11-Year Perspective for Radiopharmaceuticals by Product Type - Percentage Breakdown of Value Sales for SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types for the Years 2016, 2021 & 2027 |
| Spain Recent Past, Current & Future Analysis for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Spain Historic Review for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| Spain 11-Year Perspective for Radiopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2016, 2021 & 2027 |
| Spain Recent Past, Current & Future Analysis for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Spain Historic Review for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| Spain 11-Year Perspective for Radiopharmaceuticals by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2021 & 2027 |
| RUSSIA |
| Russia Recent Past, Current & Future Analysis for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Russia Historic Review for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| Russia 11-Year Perspective for Radiopharmaceuticals by Product Type - Percentage Breakdown of Value Sales for SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types for the Years 2016, 2021 & 2027 |
| Russia Recent Past, Current & Future Analysis for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Russia Historic Review for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| Russia 11-Year Perspective for Radiopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2016, 2021 & 2027 |
| Russia Recent Past, Current & Future Analysis for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Russia Historic Review for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| Russia 11-Year Perspective for Radiopharmaceuticals by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2021 & 2027 |
| REST OF EUROPE |
| Rest of Europe Recent Past, Current & Future Analysis for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| Rest of Europe 11-Year Perspective for Radiopharmaceuticals by Product Type - Percentage Breakdown of Value Sales for SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types for the Years 2016, 2021 & 2027 |
| Rest of Europe Recent Past, Current & Future Analysis for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| Rest of Europe 11-Year Perspective for Radiopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2016, 2021 & 2027 |
| Rest of Europe Recent Past, Current & Future Analysis for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| Rest of Europe 11-Year Perspective for Radiopharmaceuticals by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2021 & 2027 |
| ASIA-PACIFIC |
| Radiopharmaceuticals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E) |
| Market Overview |
| Asia-Pacific Recent Past, Current & Future Analysis for Radiopharmaceuticals by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Radiopharmaceuticals by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| Asia-Pacific 11-Year Perspective for Radiopharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2016, 2021 & 2027 |
| Asia-Pacific Recent Past, Current & Future Analysis for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| Asia-Pacific 11-Year Perspective for Radiopharmaceuticals by Product Type - Percentage Breakdown of Value Sales for SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types for the Years 2016, 2021 & 2027 |
| Asia-Pacific Recent Past, Current & Future Analysis for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| Asia-Pacific 11-Year Perspective for Radiopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2016, 2021 & 2027 |
| Asia-Pacific Recent Past, Current & Future Analysis for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| Asia-Pacific 11-Year Perspective for Radiopharmaceuticals by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2021 & 2027 |
| AUSTRALIA |
| Radiopharmaceuticals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2022 (E) |
| Australia Recent Past, Current & Future Analysis for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Australia Historic Review for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| Australia 11-Year Perspective for Radiopharmaceuticals by Product Type - Percentage Breakdown of Value Sales for SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types for the Years 2016, 2021 & 2027 |
| Australia Recent Past, Current & Future Analysis for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Australia Historic Review for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| Australia 11-Year Perspective for Radiopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2016, 2021 & 2027 |
| Australia Recent Past, Current & Future Analysis for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Australia Historic Review for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| Australia 11-Year Perspective for Radiopharmaceuticals by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2021 & 2027 |
| INDIA |
| Radiopharmaceuticals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2022 (E) |
| Market Overview |
| India Recent Past, Current & Future Analysis for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| India Historic Review for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| India 11-Year Perspective for Radiopharmaceuticals by Product Type - Percentage Breakdown of Value Sales for SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types for the Years 2016, 2021 & 2027 |
| India Recent Past, Current & Future Analysis for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| India Historic Review for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| India 11-Year Perspective for Radiopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2016, 2021 & 2027 |
| India Recent Past, Current & Future Analysis for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| India Historic Review for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| India 11-Year Perspective for Radiopharmaceuticals by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2021 & 2027 |
| SOUTH KOREA |
| South Korea Recent Past, Current & Future Analysis for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| South Korea Historic Review for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| South Korea 11-Year Perspective for Radiopharmaceuticals by Product Type - Percentage Breakdown of Value Sales for SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types for the Years 2016, 2021 & 2027 |
| South Korea Recent Past, Current & Future Analysis for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| South Korea Historic Review for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| South Korea 11-Year Perspective for Radiopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2016, 2021 & 2027 |
| South Korea Recent Past, Current & Future Analysis for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| South Korea Historic Review for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| South Korea 11-Year Perspective for Radiopharmaceuticals by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2021 & 2027 |
| REST OF ASIA-PACIFIC |
| Rest of Asia-Pacific Recent Past, Current & Future Analysis for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Asia-Pacific Historic Review for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| Rest of Asia-Pacific 11-Year Perspective for Radiopharmaceuticals by Product Type - Percentage Breakdown of Value Sales for SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types for the Years 2016, 2021 & 2027 |
| Rest of Asia-Pacific Recent Past, Current & Future Analysis for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Asia-Pacific Historic Review for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| Rest of Asia-Pacific 11-Year Perspective for Radiopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2016, 2021 & 2027 |
| Rest of Asia-Pacific Recent Past, Current & Future Analysis for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Asia-Pacific Historic Review for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| Rest of Asia-Pacific 11-Year Perspective for Radiopharmaceuticals by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2021 & 2027 |
| LATIN AMERICA |
| Radiopharmaceuticals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2022 (E) |
| Latin America Recent Past, Current & Future Analysis for Radiopharmaceuticals by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| Latin America Historic Review for Radiopharmaceuticals by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| Latin America 11-Year Perspective for Radiopharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2016, 2021 & 2027 |
| Latin America Recent Past, Current & Future Analysis for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Latin America Historic Review for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| Latin America 11-Year Perspective for Radiopharmaceuticals by Product Type - Percentage Breakdown of Value Sales for SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types for the Years 2016, 2021 & 2027 |
| Latin America Recent Past, Current & Future Analysis for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Latin America Historic Review for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| Latin America 11-Year Perspective for Radiopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2016, 2021 & 2027 |
| Latin America Recent Past, Current & Future Analysis for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Latin America Historic Review for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| Latin America 11-Year Perspective for Radiopharmaceuticals by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2021 & 2027 |
| ARGENTINA |
| Argentina Recent Past, Current & Future Analysis for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Argentina Historic Review for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| Argentina 11-Year Perspective for Radiopharmaceuticals by Product Type - Percentage Breakdown of Value Sales for SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types for the Years 2016, 2021 & 2027 |
| Argentina Recent Past, Current & Future Analysis for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Argentina Historic Review for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| Argentina 11-Year Perspective for Radiopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2016, 2021 & 2027 |
| Argentina Recent Past, Current & Future Analysis for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Argentina Historic Review for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| Argentina 11-Year Perspective for Radiopharmaceuticals by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2021 & 2027 |
| BRAZIL |
| Brazil Recent Past, Current & Future Analysis for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Brazil Historic Review for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| Brazil 11-Year Perspective for Radiopharmaceuticals by Product Type - Percentage Breakdown of Value Sales for SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types for the Years 2016, 2021 & 2027 |
| Brazil Recent Past, Current & Future Analysis for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Brazil Historic Review for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| Brazil 11-Year Perspective for Radiopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2016, 2021 & 2027 |
| Brazil Recent Past, Current & Future Analysis for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Brazil Historic Review for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| Brazil 11-Year Perspective for Radiopharmaceuticals by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2021 & 2027 |
| MEXICO |
| Mexico Recent Past, Current & Future Analysis for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Mexico Historic Review for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| Mexico 11-Year Perspective for Radiopharmaceuticals by Product Type - Percentage Breakdown of Value Sales for SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types for the Years 2016, 2021 & 2027 |
| Mexico Recent Past, Current & Future Analysis for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Mexico Historic Review for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| Mexico 11-Year Perspective for Radiopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2016, 2021 & 2027 |
| Mexico Recent Past, Current & Future Analysis for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Mexico Historic Review for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| Mexico 11-Year Perspective for Radiopharmaceuticals by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2021 & 2027 |
| REST OF LATIN AMERICA |
| Rest of Latin America Recent Past, Current & Future Analysis for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Latin America Historic Review for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| Rest of Latin America 11-Year Perspective for Radiopharmaceuticals by Product Type - Percentage Breakdown of Value Sales for SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types for the Years 2016, 2021 & 2027 |
| Rest of Latin America Recent Past, Current & Future Analysis for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Latin America Historic Review for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| Rest of Latin America 11-Year Perspective for Radiopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2016, 2021 & 2027 |
| Rest of Latin America Recent Past, Current & Future Analysis for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Latin America Historic Review for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| Rest of Latin America 11-Year Perspective for Radiopharmaceuticals by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2021 & 2027 |
| MIDDLE EAST |
| Radiopharmaceuticals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2022 (E) |
| Middle East Recent Past, Current & Future Analysis for Radiopharmaceuticals by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| Middle East Historic Review for Radiopharmaceuticals by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| Middle East 11-Year Perspective for Radiopharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2016, 2021 & 2027 |
| Middle East Recent Past, Current & Future Analysis for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Middle East Historic Review for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| Middle East 11-Year Perspective for Radiopharmaceuticals by Product Type - Percentage Breakdown of Value Sales for SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types for the Years 2016, 2021 & 2027 |
| Middle East Recent Past, Current & Future Analysis for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Middle East Historic Review for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| Middle East 11-Year Perspective for Radiopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2016, 2021 & 2027 |
| Middle East Recent Past, Current & Future Analysis for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Middle East Historic Review for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| Middle East 11-Year Perspective for Radiopharmaceuticals by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2021 & 2027 |
| IRAN |
| Iran Recent Past, Current & Future Analysis for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Iran Historic Review for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| Iran 11-Year Perspective for Radiopharmaceuticals by Product Type - Percentage Breakdown of Value Sales for SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types for the Years 2016, 2021 & 2027 |
| Iran Recent Past, Current & Future Analysis for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Iran Historic Review for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| Iran 11-Year Perspective for Radiopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2016, 2021 & 2027 |
| Iran Recent Past, Current & Future Analysis for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Iran Historic Review for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| Iran 11-Year Perspective for Radiopharmaceuticals by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2021 & 2027 |
| ISRAEL |
| Israel Recent Past, Current & Future Analysis for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Israel Historic Review for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| Israel 11-Year Perspective for Radiopharmaceuticals by Product Type - Percentage Breakdown of Value Sales for SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types for the Years 2016, 2021 & 2027 |
| Israel Recent Past, Current & Future Analysis for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Israel Historic Review for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| Israel 11-Year Perspective for Radiopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2016, 2021 & 2027 |
| Israel Recent Past, Current & Future Analysis for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Israel Historic Review for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| Israel 11-Year Perspective for Radiopharmaceuticals by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2021 & 2027 |
| SAUDI ARABIA |
| Saudi Arabia Recent Past, Current & Future Analysis for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Saudi Arabia Historic Review for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| Saudi Arabia 11-Year Perspective for Radiopharmaceuticals by Product Type - Percentage Breakdown of Value Sales for SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types for the Years 2016, 2021 & 2027 |
| Saudi Arabia Recent Past, Current & Future Analysis for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Saudi Arabia Historic Review for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| Saudi Arabia 11-Year Perspective for Radiopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2016, 2021 & 2027 |
| Saudi Arabia Recent Past, Current & Future Analysis for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Saudi Arabia Historic Review for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| Saudi Arabia 11-Year Perspective for Radiopharmaceuticals by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2021 & 2027 |
| UNITED ARAB EMIRATES |
| UAE Recent Past, Current & Future Analysis for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UAE Historic Review for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| UAE 11-Year Perspective for Radiopharmaceuticals by Product Type - Percentage Breakdown of Value Sales for SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types for the Years 2016, 2021 & 2027 |
| UAE Recent Past, Current & Future Analysis for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UAE Historic Review for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| UAE 11-Year Perspective for Radiopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2016, 2021 & 2027 |
| UAE Recent Past, Current & Future Analysis for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UAE Historic Review for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| UAE 11-Year Perspective for Radiopharmaceuticals by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2021 & 2027 |
| REST OF MIDDLE EAST |
| Rest of Middle East Recent Past, Current & Future Analysis for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Middle East Historic Review for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| Rest of Middle East 11-Year Perspective for Radiopharmaceuticals by Product Type - Percentage Breakdown of Value Sales for SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types for the Years 2016, 2021 & 2027 |
| Rest of Middle East Recent Past, Current & Future Analysis for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Middle East Historic Review for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| Rest of Middle East 11-Year Perspective for Radiopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2016, 2021 & 2027 |
| Rest of Middle East Recent Past, Current & Future Analysis for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Middle East Historic Review for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| Rest of Middle East 11-Year Perspective for Radiopharmaceuticals by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2021 & 2027 |
| AFRICA |
| Radiopharmaceuticals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2022 (E) |
| Africa Recent Past, Current & Future Analysis for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Africa Historic Review for Radiopharmaceuticals by Product Type - SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| Africa 11-Year Perspective for Radiopharmaceuticals by Product Type - Percentage Breakdown of Value Sales for SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Other Product Types for the Years 2016, 2021 & 2027 |
| Africa Recent Past, Current & Future Analysis for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Africa Historic Review for Radiopharmaceuticals by Application - Oncology, Cardiology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| Africa 11-Year Perspective for Radiopharmaceuticals by Application - Percentage Breakdown of Value Sales for Oncology, Cardiology, Neurology and Other Applications for the Years 2016, 2021 & 2027 |
| Africa Recent Past, Current & Future Analysis for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Africa Historic Review for Radiopharmaceuticals by End-Use - Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2019 and % CAGR |
| Africa 11-Year Perspective for Radiopharmaceuticals by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2021 & 2027 |
| IV. COMPETITION |
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com